Unfortunately it's not in their interest to do so. Once they have products in the market, yeah sure. Until then, they'll keep their heads down and focus on the research. Technically, it's more up to investment managers/brokers to market it at this point in time, and with a stock that's not generating any revenue, it's purely speculative, so they won't.
Ann: Imugene HER-Vaxx and CF33 Platforms To Feature at ASCO, page-27
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $371.8M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.8¢ | $521.9K | 10.58M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1612511 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 3882781 | 14 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |